Lantern Pharma Inc. Proceeds from Notes Payable
Lantern Pharma Inc. (LTRN) reported Proceeds from Notes Payable of $169.05 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2022-03-10
- Lantern Pharma Inc. proceeds from notes payable for the quarter ending 2020-12-31 was $0.00.
- Lantern Pharma Inc. proceeds from notes payable for the quarter ending 2020-09-30 was $0.00.
- Lantern Pharma Inc. proceeds from notes payable for the quarter ending 2020-06-30 was $102.83K.
- Lantern Pharma Inc. proceeds from notes payable for the quarter ending 2020-03-31 was $66.22K.
- Lantern Pharma Inc. proceeds from notes payable for fiscal 2020 was $169.05K.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $0.00 derived: sum of 2 quarters · filed 2022-03-10 | $102.83K derived: sum of 3 quarters · filed 2022-03-10 | $169.05K 10-K · filed 2022-03-10 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $102.83K derived: sum of 2 quarters · filed 2021-11-01 | $169.05K 10-Q · filed 2021-11-01 | |
| 2020-06-30 | $102.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $169.05K 10-Q · filed 2021-07-29 | ||
| 2020-03-31 | $66.22K 10-Q · filed 2021-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |